279 related articles for article (PubMed ID: 32817456)
1. Identification of Genomewide Alternative Splicing Events in Sequential, Isogenic Clinical Isolates of Candida albicans Reveals a Novel Mechanism of Drug Resistance and Tolerance to Cellular Stresses.
Muzafar S; Sharma RD; Shah AH; Gaur NA; Dasgupta U; Chauhan N; Prasad R
mSphere; 2020 Aug; 5(4):. PubMed ID: 32817456
[TBL] [Abstract][Full Text] [Related]
2. Loss of Upc2p-Inducible
Luna-Tapia A; Willems HME; Parker JE; Tournu H; Barker KS; Nishimoto AT; Rogers PD; Kelly SL; Peters BM; Palmer GE
mBio; 2018 May; 9(3):. PubMed ID: 29789366
[TBL] [Abstract][Full Text] [Related]
3. Mutations and/or Overexpressions of ERG4 and ERG11 Genes in Clinical Azoles-Resistant Isolates of Candida albicans.
Feng W; Yang J; Xi Z; Qiao Z; Lv Y; Wang Y; Ma Y; Wang Y; Cen W
Microb Drug Resist; 2017 Jul; 23(5):563-570. PubMed ID: 27976986
[TBL] [Abstract][Full Text] [Related]
4. Reduced susceptibility of Candida albicans clinical isolates to azoles and detection of mutations in the ERG11 gene.
Zhang L; Yang HF; Liu YY; Xu XH; Ye Y; Li JB
Diagn Microbiol Infect Dis; 2013 Dec; 77(4):327-9. PubMed ID: 24070847
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
Sanglard D; Kuchler K; Ischer F; Pagani JL; Monod M; Bille J
Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
[TBL] [Abstract][Full Text] [Related]
6. Assessment of antifungal resistance and associated molecular mechanism in Candida albicans isolates from different cohorts of patients in North Indian state of Haryana.
Kumar A; Nair R; Kumar M; Banerjee A; Chakrabarti A; Rudramurthy SM; Bagga R; Gaur NA; Mondal AK; Prasad R
Folia Microbiol (Praha); 2020 Aug; 65(4):747-754. PubMed ID: 32219719
[TBL] [Abstract][Full Text] [Related]
7. Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans.
Nishimoto AT; Sharma C; Rogers PD
J Antimicrob Chemother; 2020 Feb; 75(2):257-270. PubMed ID: 31603213
[TBL] [Abstract][Full Text] [Related]
8. Loss of C-5 Sterol Desaturase Activity in
Luna-Tapia A; Butts A; Palmer GE
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30323044
[TBL] [Abstract][Full Text] [Related]
9. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Sanglard D; Coste AT
Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India.
Mane A; Vidhate P; Kusro C; Waman V; Saxena V; Kulkarni-Kale U; Risbud A
Mycoses; 2016 Feb; 59(2):93-100. PubMed ID: 26648048
[TBL] [Abstract][Full Text] [Related]
11. RTA2, a novel gene involved in azole resistance in Candida albicans.
Jia XM; Ma ZP; Jia Y; Gao PH; Zhang JD; Wang Y; Xu YG; Wang L; Cao YY; Cao YB; Zhang LX; Jiang YY
Biochem Biophys Res Commun; 2008 Sep; 373(4):631-6. PubMed ID: 18601908
[TBL] [Abstract][Full Text] [Related]
12.
Nishimoto AT; Wiederhold NP; Flowers SA; Zhang Q; Kelly SL; Morschhäuser J; Yates CM; Hoekstra WJ; Schotzinger RJ; Garvey EP; Rogers PD
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910896
[TBL] [Abstract][Full Text] [Related]
13. Stable phenotypic resistance of Candida species to amphotericin B conferred by preexposure to subinhibitory levels of azoles.
Vazquez JA; Arganoza MT; Boikov D; Yoon S; Sobel JD; Akins RA
J Clin Microbiol; 1998 Sep; 36(9):2690-5. PubMed ID: 9705415
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals.
Eddouzi J; Parker JE; Vale-Silva LA; Coste A; Ischer F; Kelly S; Manai M; Sanglard D
Antimicrob Agents Chemother; 2013 Jul; 57(7):3182-93. PubMed ID: 23629718
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanism of azoles resistant Candida albicans in a patient with chronic mucocutaneous candidiasis.
Zhang MR; Zhao F; Wang S; Lv S; Mou Y; Yao CL; Zhou Y; Li FQ
BMC Infect Dis; 2020 Feb; 20(1):126. PubMed ID: 32046674
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of resistance to fluconazole in Candida albicans clinical isolates from Iranian HIV-infected patients with oropharyngeal candidiasis.
Salari S; Khosravi AR; Mousavi SA; Nikbakht-Brojeni GH
J Mycol Med; 2016 Mar; 26(1):35-41. PubMed ID: 26627124
[TBL] [Abstract][Full Text] [Related]
17. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA
Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783
[TBL] [Abstract][Full Text] [Related]
18. Genetic Analysis of
Kim SH; Iyer KR; Pardeshi L; Muñoz JF; Robbins N; Cuomo CA; Wong KH; Cowen LE
mBio; 2019 Jan; 10(1):. PubMed ID: 30696744
[No Abstract] [Full Text] [Related]
19. Triazole Evolution of Candida parapsilosis Results in Cross-Resistance to Other Antifungal Drugs, Influences Stress Responses, and Alters Virulence in an Antifungal Drug-Dependent Manner.
Papp C; Bohner F; Kocsis K; Varga M; Szekeres A; Bodai L; Willis JR; Gabaldón T; Tóth R; Nosanchuk JD; Vágvölgyi C; Gácser A
mSphere; 2020 Oct; 5(5):. PubMed ID: 33115837
[TBL] [Abstract][Full Text] [Related]
20. Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin.
Singh SD; Robbins N; Zaas AK; Schell WA; Perfect JR; Cowen LE
PLoS Pathog; 2009 Jul; 5(7):e1000532. PubMed ID: 19649312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]